Page 2 of 2
Siesta, Inemuri, and the 30-Minute Rule: What Napping Looks Like Around the World
In a meta-analysis of 1.86 million people, naps under 30 minutes carried no significant risk association. 58 percent of Spaniards never nap; Japan naps by rule.
Migraine Prevention Access: Same Drug, Same Results, Different Fine Print by Country
CGRP migraine prevention: a Korea-Japan comparison found identical response rates. Korea reimburses after three failed drugs in six months, Japan after one.
Lower Back Pain: Why the Scan Shows Nothing, and How Four Countries Cope
Back pain is the world's leading cause of disability, and at least 90 percent of chronic primary-care cases are estimated to have no lesion a scan can find.
Hair Loss Treatment: What Works, and Why the Warnings Differ by Country
Topical minoxidil and oral finasteride are the FDA-approved options. Japan grades every treatment A to D, and UK regulators strengthened warnings in May 2026.
Insomnia Treatment: Why the Guidelines Put CBT-I Before Sleeping Pills
First-line treatment for chronic insomnia is CBT-I, not medication, and the 2026 guideline advises against adding sleeping pills to it.
Period Pain Relief That Actually Works: The Guideline Says Stop Normalizing It
First-line treatment for dysmenorrhea is NSAIDs and hormonal contraception, and the SOGC guideline says the condition is frequently normalized and undertreated.
What Causes Sleep Paralysis, and Why the Room Feels Occupied
Sleep paralysis is REM muscle atonia carrying into waking. What causes it, the three hallucination types, when to see a doctor, and what five countries call it.